Product image of Morphanton (Morphine Sulfate) supplied by GNH India

Morphanton

Active Ingredient:
Morphine Sulfate
Origin:
EU

Morphanton (Morphine Sulfate)

Morphine sulfate, the active ingredient in Morphanton, is an opioid analgesic presented as an oral formulation for oral use. It is employed to manage moderate to severe pain in adult patients when other analgesics are insufficient.

GNH India supplies Morphanton as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for export to multiple regions. Clients benefit from reliable logistics, temperature‑controlled shipping where required, and responsive technical support throughout the procurement process.

Manufacturer / TM Owner

Juta Pharma Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Morphine sulfate is indicated for pain management across several clinical contexts where opioid therapy is appropriate.

  • Acute postoperative pain: provides rapid analgesia to facilitate recovery after surgery.
  • Cancer‑related pain: controls moderate to severe pain associated with malignant disease.
  • Severe chronic non‑cancer pain: offers long‑term relief when other treatments are inadequate.

How It Works

  • Morphine sulfate acts as a full agonist at the μ‑opioid receptors in the central nervous system. By binding to these G‑protein‑coupled receptors, it inhibits the release of nociceptive neurotransmitters, reduces neuronal excitability, and alters pain perception, producing potent analgesic effects.

Side Effects

Morphine sulfate may cause a range of adverse reactions, varying from mild to potentially life‑threatening.

Common Side Effects

  • Constipation: reduced gastrointestinal motility leading to hard stools.
  • Nausea and vomiting: stimulation of the chemoreceptor trigger zone.
  • Drowsiness or sedation: central nervous system depression.
  • Dry mouth: decreased salivary secretion.
  • Pruritus: histamine release causing itching.

Serious or Rare Side Effects

  • Respiratory depression: decreased respiratory drive that can be fatal.
  • Hypotension: significant drop in blood pressure.
  • Severe allergic reaction: rash, swelling, or anaphylaxis.
  • Dependence and withdrawal: risk of physical dependence with prolonged use.

Precautions & Warnings

When prescribing Morphanton, clinicians should consider several safety measures to minimize risk.

  • Assess pain severity and prior opioid exposure: ensure opioid therapy is justified.
  • Evaluate respiratory function: avoid use in patients with compromised breathing.
  • Monitor for signs of sedation or CNS depression: especially during dose titration.
  • Use caution in renal or hepatic impairment: dose adjustments may be required.
  • Avoid concurrent use with other central nervous system depressants: increase risk of respiratory depression.
  • Store at ambient temperature: keep in original container, protect from moisture and light.

Avoid Interactions

Morphine sulfate can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid)

  • Concurrent use with other opioids or strong CNS depressants: may cause profound respiratory depression.
  • MAO inhibitors or within 14 days of discontinuation: risk of severe hypertension or serotonin syndrome.
  • High‑dose benzodiazepines: synergistic sedation and respiratory effects.

Moderate Interactions (Monitor Closely)

  • CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): may increase morphine plasma levels.
  • CYP3A4 inducers (e.g., rifampin, carbamazepine): may reduce analgesic effect.
  • Anticholinergic agents: may exacerbate constipation.
  • Diuretics: can enhance hypotensive effects.

Frequently Asked Questions

Morphanton contains morphine sulfate and is used to relieve moderate to severe pain when non‑opioid analgesics are insufficient. It is prescribed for acute postoperative pain, cancer‑related pain, and severe chronic non‑cancer pain in adult patients.

Morphine sulfate binds to μ‑opioid receptors in the brain and spinal cord, activating G‑protein pathways that inhibit the release of pain‑transmitting neurotransmitters. This reduces neuronal excitability and alters the perception of pain, providing strong analgesic effects.

The appropriate dose of Morphanton is individualized by the prescribing clinician based on the patient’s pain intensity, prior opioid exposure, and clinical condition. Dosage regimens are not standardized and must follow the prescriber’s orders.

Safety data for morphine sulfate in pregnancy and lactation are limited. Because opioids can cross the placenta and appear in breast milk, Morphanton is generally avoided unless the potential benefit justifies the potential risk to the fetus or infant.

To request Morphanton, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and import documentation.

Morphanton (morphine sulfate) is a prototypical μ‑opioid agonist with a well‑characterized efficacy and safety profile. Compared with newer opioids such as oxycodone, morphine has a longer history of use, a predictable metabolism, and is often less expensive, though individual response and side‑effect tolerance may vary.

Morphanton should be stored at ambient temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and do not use it after the expiration date.

Morphanton is formulated for oral administration. It is taken by mouth with or without food, according to the prescriber’s instructions. Swallow tablets whole; do not crush or chew unless specifically directed by a healthcare professional.

The most serious risks include respiratory depression, profound sedation, hypotension, severe constipation leading to bowel obstruction, and the potential for physical dependence or addiction. Immediate medical attention is required if breathing becomes shallow, the patient becomes excessively drowsy, or any signs of an allergic reaction appear.

Morphanton should be avoided in patients with known hypersensitivity to morphine or other opioids, those with severe respiratory insufficiency, uncontrolled asthma, or paralytic ileus. Caution is also advised for individuals with significant hepatic or renal impairment, and it is contraindicated in patients receiving monoamine oxidase inhibitors.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Morphine Sulfate

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT